Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

NCT02576847 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
307
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Maruho Co., Ltd.